NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Poly Medicure Limited (NSE: POLYMED)
POLYMED Technical Analysis
5
As on 27th Mar 2024 POLYMED SHARE Price closed @ 1584.65 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1332.28 & Strong Buy for SHORT-TERM with Stoploss of 1517.68 we also expect STOCK to react on Following IMPORTANT LEVELS. |
POLYMEDSHARE Price
Open | 1557.00 | Change | Price | % |
High | 1590.00 | 1 Day | 27.45 | 1.76 |
Low | 1557.00 | 1 Week | 87.95 | 5.88 |
Close | 1584.65 | 1 Month | -40.65 | -2.50 |
Volume | 22406 | 1 Year | 615.60 | 63.53 |
52 Week High 1272.30 | 52 Week Low 667.75 |
NSE INDIA Most Active Stocks
IDEA | 13.30 | 0.00% |
YESBANK | 23.15 | -1.70% |
NHPC | 88.85 | 3.68% |
SUZLON | 38.50 | 3.77% |
IRFC | 142.85 | -1.96% |
RAMASTEEL | 14.15 | 9.27% |
ZEEL | 141.35 | 1.51% |
INFIBEAM | 34.80 | 0.14% |
IDFCFIRSTB | 77.80 | 0.13% |
DISHTV | 16.80 | -2.04% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
POLYMED Daily Charts |
POLYMED Intraday Charts |
Whats New @ Bazaartrend |
POLYMED Free Analysis |
|
POLYMED Important Levels Intraday
RESISTANCE | 1648.24 |
RESISTANCE | 1627.85 |
RESISTANCE | 1615.24 |
RESISTANCE | 1602.64 |
SUPPORT | 1566.67 |
SUPPORT | 1554.06 |
SUPPORT | 1541.45 |
SUPPORT | 1521.06 |
POLYMED Target March 2024
4th UP Target | 2089.13 |
3rd UP Target | 1893.84 |
2nd UP Target | 1773.13 |
1st UP Target | 1652.42 |
1st DOWN Target | 1307.98 |
2nd DOWN Target | 1187.27 |
3rd DOWN Target | 1066.56 |
4th DOWN Target | 871.27 |
POLYMED Weekly Target
4th UP Target | 1884.97 |
3rd UP Target | 1779.32 |
2nd UP Target | 1714.02 |
1st UP Target | 1648.72 |
1st DOWN Target | 1462.38 |
2nd DOWN Target | 1397.08 |
3rd DOWN Target | 1331.78 |
4th DOWN Target | 1226.13 |
POLYMED Target2024
4th UP Target | 3140.76 |
3rd UP Target | 2611.32 |
2nd UP Target | 2284.06 |
1st UP Target | 1956.8 |
1st DOWN Target | 1023 |
2nd DOWN Target | 695.74 |
3rd DOWN Target | 368.48 |
4th DOWN Target | -160.96 |
Poly Medicure Limited ( NSE INDIA Symbol : POLYMED )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
POLYMED Synopsis Technicals View
50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
RSI (14) | RSI is 34.16 | Sideways | |
MFI (14) | MFI is 37.62 | Sideways | |
CCI (20) | CCI is Below -100 | Over Sold | |
WILLIAM %R (14) | William %R is -79.06 | Sideways | |
ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
PSAR | Stoploss For Long Buy | 285.06 | |
10 Day Avg Volume | Traded -47.79 % Less then 10 Day Average Volume |
POLYMED Other Details
Segment | EQ | |
Market Capital | 87400038400.00 | |
Sector | Healthcare | |
Industry | Medical Instruments & Supplies | |
Offical website | > echo $website ; ?> |
POLYMED Address
POLYMED Latest News
POLYMED Business Profile
Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India. Address: 232B Okhla Industrial Estate, New Delhi, India, 110020
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service